Bupivacaine Hydrochloride for Pain Control in Cutaneous Surgery
Enrolling by invitation · Phase 1
Conditions studied: Pain, Postoperative
In brief
The purpose of this study is to determine if the addition of bupivacaine HCl injections will improve pain control after skin surgery. This is a randomized clinical trial. Approximately 100 participants will be randomized to receive either bupivacaine HCl or saline injections to help with the postsurgical pain. Patients will be provided with a take-home journal to complete indicating when and how much pain medication they required for the 3 days immediately following surgery. Participants will return the journal in-person at a follow up visit 7-21 days post-op. This study was a pilot study designed to determine the feasibility of this procedure. Subjects currently living in the Chicago metropolitan area and meet inclusion/exclusion criteria will be invited and considered for enrollment.
Key facts
- Study ID
- NCT04260854
- Run by
- Northwestern University
- People needed
- 100
- Starts
- 2024-01-24
- Expected to finish
- 2028-12-01
- Last updated by the study team
- 2026-07-01
Who can join
Age: 19 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- >18 years of age
- Receiving cutaneous surgery
- In good general health as assessed by the investigator
You may not qualify if…
- Participants with an allergy to bupivacaine or other amide anesthetics
- Participants unwilling to sign an IRB approved consent form
- Participants with a contraindication to narcotic medication
- Participants who are pregnant or will become pregnant
- Participants who are unable to communicate or cooperate with the investigator due to language problems, poor mental development, or impaired cerebral function are not eligible
Where it is running
- Northwestern University Department of Dermatology — Chicago, Illinois, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.